Major Study Finds No Link Between Antidepressants During Pregnancy and Autism Risk
Translated from Arabic, summarized and contextualized by DistantNews.
At a glance
- An international study analyzing data from nearly 25 million pregnancies found no increased risk of developmental disorders, including autism, associated with antidepressant use during pregnancy.
- The findings, published in The Lancet Psychiatry, contradict claims made by Robert F. Kennedy Jr. linking certain antidepressants to autism risk without scientific evidence.
- Researchers concluded that while a slight increase in diagnoses was observed, it was largely attributable to factors like family history and maternal mental health, not the medication itself.
In a significant development for public health and maternal care, a comprehensive international study has provided reassuring evidence regarding the use of antidepressants during pregnancy. Published in the prestigious journal The Lancet Psychiatry, the research analyzed data from an astounding 25 million pregnancies, concluding that common antidepressants do not elevate the risk of neurodevelopmental disorders, such as autism or ADHD, in children.
This study directly addresses and refutes concerns, notably amplified by figures like Robert F. Kennedy Jr., who have suggested a link between these medications and autism. Our medical community, and indeed many expectant mothers, have been awaiting such definitive scientific clarification. The research, led by Dr. Wing Chung Cheung from the University of Hong Kong, offers "reassuring evidence" that the benefits of managing maternal mental health with these medications likely outweigh any minimal, and often confounding, risks.
The results provide reassuring evidence regarding the safety of commonly used antidepressants during pregnancy.
The findings are particularly important in the context of mental health awareness and treatment. Untreated depression during pregnancy can have serious consequences for both mother and child. This study empowers healthcare providers and patients with robust data, affirming that informed decisions can be made about managing maternal mental well-being without undue fear of causing developmental harm. The rigorous methodology, which accounted for various confounding factors, strengthens the validity of the conclusion that the medications themselves are not the primary drivers of observed diagnostic increases.
the analysis did not find a confirmed increase in the risk of autism or ADHD in children.
Originally published by Hespress in Arabic. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.